Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CIBC Asset Management Inc reduced its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 415,725 shares of the biopharmaceutical company’s stock after selling 13,985 shares during the period. […]
Capital Counsel LLC NY reduced its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.1% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 69,310 shares of the biopharmaceutical company’s stock after selling 804 shares during the period. Gilead Sciences accounts for about 0.3% of Capital Counsel LLC NY’s […]
Capital Counsel LLC NY lowered its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 69,310 shares of the biopharmaceutical company’s stock after selling 804 shares during the period. Gilead […]
Continental Advisors LLC cut its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 16.8% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 81,903 shares of the biopharmaceutical company’s stock after selling 16,500 shares during the quarter. Gilead Sciences comprises 2.9% of Continental Advisors LLC’s holdings, making the stock its 9th […]
Continental Advisors LLC decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 16.8% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 81,903 shares of the biopharmaceutical company’s stock after selling 16,500 shares during the period. Gilead Sciences makes up approximately 2.9% of […]